Before revision: Administration of the partial inverse agonist, FG 7142 , to the GABAA receptor resulted in attenuated recovery in both the ABA and ABB test scenarios.
After revision: Administration of the partial inverse agonist, FG-7142 , to the GABAA receptor resulted in attenuated recovery in both the ABA and ABB test scenarios.